“Management of Metabolic Effects Associated with Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway”, J Clin Oncol, vol. 30, pp. 2919-2928, 2012.
, “The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: Summary and Recommendations”, J Oncol Pract, vol. 9, pp. 267-276, 2013.